Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns

Emergencies Clinical Trial

Official title:

The Impact of the Qatar 2022 FIFA World Cup During Winter Epidemics on Paediatric Emergency Department Use and Misuse Patterns: a Multicentre, Retrospective, Population-based Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05818215
• Other study ID #: FIFA World Cup Qatar 2022
• Status: Completed
• Start date: September 1, 2021
• Est. completion date: January 20, 2023

Study information

• Verified date: April 2023
• Source: Pediatric Clinical Research Platform
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A retrospective cohort study to explore the impact of the FIFA World Cup 2022 Qatar on paediatric emergency department attendance at two tertiary centres during unprecedent winter viral epidemics.

Description:

Earlier studies have reported contradictory relationship between major sporting events and paediatric emergency department attendance. None were conducted during an epidemic surge. The FIFA football World Cup 2022 was held for the first time in its history during the winter period in the northern hemisphere during unprecedented cumulative waves of respiratory syncitial virus (RSV), influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics. This study aims to measure the impact of such a global major sporting events on the pattern of paediatric emergency department use and hospital admissions during a peak epidemic season in 2 tertiary hospitals. The study hypothesis was that major sporting events, even during an epidemic peak, can reduce the number of paediatric emergency department visits compared with periods without a sporting event. Major sporting events could serve as a model for identifying human behaviours and patterns leading to paediatric emergency department misuse, in order to develop public health interventions to better rationalise health-seeking behaviours.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18000
• Est. completion date: January 20, 2023
• Est. primary completion date: January 20, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 16 Years

Eligibility

Inclusion Criteria:

• all patients

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Electronic Medical Record
• Emergencies
• Epidemic Disease
• Pediatric ALL

Intervention

Other:
• NO intervention
NO intervention

Locations

Country	Name	City	State
Switzerland	Geneva Children's Hospital	Geneva

Sponsors (2)

Lead Sponsor	Collaborator
Pediatric Clinical Research Platform	University of Lausanne Hospitals

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PED visits	Retrospective analysis of number of PED visits (counts).	Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary	Triage acuity score	Retrospective analysis of number of PED visits (counts) by triage acuity score (coded using the 5-level Canadian Triage and Acuity Scale (from level 1 [resuscitation] to level 5 [nonurgent]).	Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary	Chief complaint	Retrospective analysis of number of PED visits (counts) by chief complaints.	Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary	Main diagnosis	Retrospective analysis of number of PED visits (counts) by main diagnosis (coded using the International Classification of Primary Care, 2nd edition [ICPC-2], and International Statistical Classification of Diseases and Related Health Problems, 10th revision [ICD-10-GM]).	Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary	Audience	Daily television and online media audience collected by the independent, multi-platform Swiss national foundation for media research (Mediapulse AG, Bern, Switzerland).	Analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary	RSV incidence	RSV-incidence estimates among children will be obtained from the anonymised Swiss RSV EpiCH multicentre database. RSV testing uses reverse-transcription polymerase chain reaction or rapid antigen test at the point of care.	Analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary	Influenza incidence	Influenza-incidence among children visiting the PED during the study period will be obtained from the institutional electronic medical records. RSV testing on nasopharyngeal swabs uses reverse-transcription polymerase chain reaction at the point of care.	Analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary	SARS-CoV-2 incidence	SARS-CoV-2-incidence among children visiting the PED during the study period will be obtained from the institutional electronic medical records. SARS-CoV-2 testing on nasopharyngeal swabs uses reverse-transcription polymerase chain reaction at the point of care.	Analysed retrospectively from October 1st, 2022 to December 31, 2022